FR2774263A1 - Food supplement for reducing levels of monounsaturated fatty acids responsible for fat accumulation in body tissues - Google Patents

Food supplement for reducing levels of monounsaturated fatty acids responsible for fat accumulation in body tissues Download PDF

Info

Publication number
FR2774263A1
FR2774263A1 FR9801271A FR9801271A FR2774263A1 FR 2774263 A1 FR2774263 A1 FR 2774263A1 FR 9801271 A FR9801271 A FR 9801271A FR 9801271 A FR9801271 A FR 9801271A FR 2774263 A1 FR2774263 A1 FR 2774263A1
Authority
FR
France
Prior art keywords
fatty acids
body tissues
fat accumulation
monounsaturated fatty
food supplement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR9801271A
Other languages
French (fr)
Inventor
Yann Gourdel
Jacqueline Tronel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR9801271A priority Critical patent/FR2774263A1/en
Publication of FR2774263A1 publication Critical patent/FR2774263A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Human or veterinary food or dietary supplement based on conjugated linoleic acid encapsulated in a gelatin or cellulose derivative film, is new. An Independent claim is included for a product based mainly on conjugated linoleic acid encapsulated in gelatin or cellulose derivatives, for reducing monounsaturated fatty acid levels in tissue which are responsible for fat accumulation.

Description

-1- La présente invention concerne l'application et l'emploi d'acide-1- The present invention relates to the application and use of acid

linoléique conjugué ( CLA) ( acide 9,11-10,12 10,12 octadecadienoique cis et trans)  conjugated linoleic (CLA) (9,11-10,12,10,12 octadecadienoic cis and trans)

sous forme de capsules de gélatine lubrifiées ou de dérivés de cellulose.  in the form of lubricated gelatin capsules or cellulose derivatives.

en complémentation alimentaire humaine et vétérinaire ou dans les produits diététiques dans le but d'appauvrir les divers tissus corporels en acides gras  in human and veterinary food supplementation or in dietetic products in order to deplete the various body tissues with fatty acids

mono-insaturés responsable des amas graisseux.  mono-unsaturated responsible for fatty deposits.

Cette invention se traduit par l'emploi de l'acide linoléique conjuguée CLA sous forme de capsules molles à des doses allant de 150 mg à 3 g pour  This invention results in the use of CLA conjugated linoleic acid in the form of soft capsules at doses ranging from 150 mg to 3 g for

obtenir l'action précitée dans les compléments alimentaires.  obtain the aforementioned action in food supplements.

formule - Acide 9,11- 10,12 octadecadiènoique cis et trans en concentration supérieure à 60% de 150 mg à 3 000 mg - gélatine de 150 mg à 500 mg - Composés technologiques nécessaire à l'encapsulation et la bonne  formula - Acid 9,11- 10,12 octadecadiènoique cis and trans in concentration greater than 60% from 150 mg to 3000 mg - gelatin from 150 mg to 500 mg - Technological compounds necessary for the encapsulation and the good

utilisation de ces capsules.use of these capsules.

-2--2-

Claims (2)

REVENDICATIONS 1) Complément alimentaire ou diététique humain ou vétérinaire à base de'acide linoléique conjugué encapsulé dans une pellicule de gélatine ou de dérivés de cellulose.  1) Human or veterinary dietary supplement based on conjugated linoleic acid encapsulated in a film of gelatin or cellulose derivatives. 2) Produit à base majoritaire de CLA encapsulé dans de la gélatine ou de dérivé2) Product based mainly on CLA encapsulated in gelatin or derivative de cellulose permettant d'appauvrir les tissus corporels en acides gras mono-  cellulose to deplete body tissues of mono- fatty acids insaturés responsable des amas graisseux.  unsaturated responsible for fatty deposits.
FR9801271A 1998-02-02 1998-02-02 Food supplement for reducing levels of monounsaturated fatty acids responsible for fat accumulation in body tissues Withdrawn FR2774263A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9801271A FR2774263A1 (en) 1998-02-02 1998-02-02 Food supplement for reducing levels of monounsaturated fatty acids responsible for fat accumulation in body tissues

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9801271A FR2774263A1 (en) 1998-02-02 1998-02-02 Food supplement for reducing levels of monounsaturated fatty acids responsible for fat accumulation in body tissues

Publications (1)

Publication Number Publication Date
FR2774263A1 true FR2774263A1 (en) 1999-08-06

Family

ID=9522568

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9801271A Withdrawn FR2774263A1 (en) 1998-02-02 1998-02-02 Food supplement for reducing levels of monounsaturated fatty acids responsible for fat accumulation in body tissues

Country Status (1)

Country Link
FR (1) FR2774263A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2355382A (en) * 1999-08-24 2001-04-25 Gilbertson & Page Ltd Conjugated linoleic acid for weight reduction in a dog

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2355382A (en) * 1999-08-24 2001-04-25 Gilbertson & Page Ltd Conjugated linoleic acid for weight reduction in a dog

Similar Documents

Publication Publication Date Title
JP5827784B2 (en) Medicines and nutritional supplements containing vitamin K2
Takahashi et al. Reduction in formation and growth of 1, 2-dimethylhydrazine-induced aberrant crypt foci in rat colon by docosahexanoic acid
EP0347056B1 (en) Essential fatty acid compositions
JPS6296422A (en) Manufacture of preventive or therapeutic composition for endometric proliferation and prevention or remedy therefor
DK1121115T3 (en) PUFA supplements
ATE456645T1 (en) FUNCTIONAL ACYL GLYCERIDES
WO2001017517A2 (en) Use of g(a)-linolenic acid metabolites in the manufacture of a medicament for the treatment or prevention of cancer
KR100458659B1 (en) Food products and methods for preventing and improving medical symptoms caused by abnormalities in cartilage tissue containing omega 9 unsaturated fatty acids
EP0769917B1 (en) Nervonic acid compositions
US20140302128A1 (en) Biological oil composition, formulations comprising the oil composition, and use thereof to prevent or treat cardiovascular disease
Bartoli et al. n-3 pufa and α-tocopherol control of tumor cell proliferation
CA2000396A1 (en) Triglycerides, composition comprising such triglycerides, and use of such composition
FR2774263A1 (en) Food supplement for reducing levels of monounsaturated fatty acids responsible for fat accumulation in body tissues
JP4205432B2 (en) Bone metabolism improver
LU87170A1 (en) DIETITIC COMPOSITIONS AND PROCESS FOR THEIR PREPARATION
JP2001029010A (en) Nutrient composition
Levitsky The role of polyunsaturated fatty acids (PUFA) in the formation of the structure and functions of biomembranes
JP3917825B2 (en) Angiogenesis inhibitor
AU711302C (en) Nervonic acid compositions
JPS62187425A (en) Composition containing linolenic acid and its derivative
FR2770976A1 (en) Plant-based food supplement contains Dioscorea extract
OKITA et al. Beneficial Effect Polyunsaturated Fatty Acid-Supplemented Diet on Altered Composition of Plasma Fatty Acids in Patients with Liver Cirrhosis
JP2009084244A (en) Skin barrier function improving agent and the like
JPWO2003074042A1 (en) Uncoupling protein expression enhancer

Legal Events

Date Code Title Description
ST Notification of lapse